Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases
Volume 9 (1998), Issue 4, Pages 215-228
http://dx.doi.org/10.1155/1998/831425
Original Article

Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects

George G Zhanel,1 Andrew E Simor,3 Lavern Vercaigne,2 Lionell Mandell,4 and the Canadian Carbapenem Discussion Group

1Departments of Medicine and Microbiology, Health Sciences Centre and Faculties of Pharmacy and Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
2Department of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada
3Department of Microbiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
4Department of Infectious Diseases, McMaster University, Hamilton, Ontario, Canada

Received 11 June 1997; Accepted 11 November 1997

Copyright © 1998 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

George G Zhanel, Andrew E Simor, Lavern Vercaigne, Lionell Mandell, and the Canadian Carbapenem Discussion Group, “Imipenem and Meropenem: Comparison of In Vitro Activity, Pharmacokinetics, Clinical Trials and Adverse Effects,” Canadian Journal of Infectious Diseases, vol. 9, no. 4, pp. 215-228, 1998. doi:10.1155/1998/831425